| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/16/2008 | CN101220044A Telomerase inhibitor, preparation method and application thereof |
| 07/16/2008 | CN101220037A 10-substitution homocamptothecin compounds and uses |
| 07/16/2008 | CN101220035A A kind of alkaloid, method for preparing the same and application in antineoplastic or antimicrobial aspects |
| 07/16/2008 | CN101220033A Synthesis of temozolomide and analogs |
| 07/16/2008 | CN101220031A Acyclic purine nucleosides derivant and method of preparing the same |
| 07/16/2008 | CN101220028A Urea substituted imidazopyridines |
| 07/16/2008 | CN101220024A A set of anti-cancer compound restraining kinase |
| 07/16/2008 | CN101220014A Meletin with cell apoptosis inductive effect and metallic complex of glycoside compounds thereof |
| 07/16/2008 | CN101220008A Synthesis of compound ABT-263 |
| 07/16/2008 | CN101219999A N- (3-ethynylphenyl) -6, 7-bis (2-methoxyethoxy) -4-quinazolinamine mesylate anhydrate and monohydrate |
| 07/16/2008 | CN101219998A Acyclic pyrimidine nucleoside derivant and method for producing the same |
| 07/16/2008 | CN101219222A Application of PDCD4 recombined expression vector in preparing medicament for treating gonad cancer |
| 07/16/2008 | CN101219219A Complex containing vascellum chalone or its fragment, preparation method and application thereof |
| 07/16/2008 | CN101219189A Clinical application of Chinese medicinal herb for treating cancer of the lungs |
| 07/16/2008 | CN101219184A Health care breast protecting film and technique of preparing the same |
| 07/16/2008 | CN101219162A Tumor eliminating prescription |
| 07/16/2008 | CN101219149A Auricularia polytricha polyoses grain medicinal granules and method for preparing the same |
| 07/16/2008 | CN101219145A Quinazoline derivatives as VEGF inhibitors |
| 07/16/2008 | CN101219144A Long-circulation nano-grain of hydroxycamptothecin and method for preparing the same |
| 07/16/2008 | CN101219142A Method for preparing small-molecule antineoplastic medicament with specificity for CYP2J2 and medical use thereof |
| 07/16/2008 | CN101219137A Treatment of esophageal high grade dysplasia using photodynamic therapy |
| 07/16/2008 | CN101219135A Application of zedoary root cyclic diolefine in preparing medicament for treating tumour disease and disease caused by virus |
| 07/16/2008 | CN101219113A Compound anticancer sustained-release injection containing bendamustine |
| 07/16/2008 | CN101219112A Compound anticancer sustained-release injection containing bendamustine |
| 07/16/2008 | CN101219111A Anticancer injection containing bendamustine and its potentiating agent |
| 07/16/2008 | CN101219110A Sustained-release injection containing methotrexate potentiating agent |
| 07/16/2008 | CN101219107A Imatinib sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219106A Telatinib sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219105A Emtricitabine sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219104A Cladribine sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219103A Tipifarnib sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219102A Lapatinib sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN101219101A Fludarabine sustained-release implantation agent for treating solid tumors |
| 07/16/2008 | CN100402648C Human Nanog gene and its encoded protein and application |
| 07/16/2008 | CN100402554C Preparation and use of testes specificity protein 50 human source antibody |
| 07/16/2008 | CN100402551C Antigen epitope of beta2-microglobulin and its application |
| 07/16/2008 | CN100402546C Steroid compounds with anti-tumor activity |
| 07/16/2008 | CN100402539C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402523C Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
| 07/16/2008 | CN100402517C 9-anthrone lactone compounds, preparing method and use thereof |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
| 07/16/2008 | CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia |
| 07/16/2008 | CN100402483C Process of extracting cimitt acid |
| 07/16/2008 | CN100402091C Anticarcinogen composition |
| 07/16/2008 | CN100402085C Production of high-concentration thymic peptide solution and large-specification thymic peptide preparation |
| 07/16/2008 | CN100402078C Medicinal pills for clearing liver heat, dispelling toxic materials and promoting diuresis |
| 07/16/2008 | CN100402031C Parenteral formulations containing a rapamycin hydroxyester |
| 07/16/2008 | CN100402029C Combinations comprising epothilone derivatives and alkylating agent |
| 07/16/2008 | CN100402022C Application of erigeron breviscapus and Scutellarin in preparing medication anti tumor |
| 07/16/2008 | CN100402020C Medicinal formulation in particular for treating herniated invertebral discs |
| 07/16/2008 | CN100402017C Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399860 Manufacture of polyglutamate-therapeutic agent conjugates |
| 07/15/2008 | US7399849 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 07/15/2008 | US7399835 Cancerous disease modifying antibodies |
| 07/15/2008 | US7399829 Variants of RANKL protein |
| 07/15/2008 | US7399827 For diagnosis and for vaccine based therapy of neoplasms of prostate, testis and uterus; inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers |
| 07/15/2008 | US7399770 N-(hydroxy)-2-(4'-chlorobiphenyl-4-sulfonyl)-4-hydroxy-1,2,3,4-tetrahydrobenzo[4,5]thieno[3,2-c]pyridine-1-carboxamide; collagenase inhibitor; antiinflammatory, angiogenesis agent, wound healing agent; arthritis, multiple sclerosis, osteoarthrosis, atherosclerosis, restenosis, myocardial infarction |
| 07/15/2008 | US7399761 Phthalazine derivatives with angiogenesis inhibiting activity |
| 07/15/2008 | US7399748 Intravenous administration of a alpha -halogen- acryloyl distamycin derivative for therapy of tumors |
| 07/15/2008 | US7399747 Peptides carrying substances across the blood brain barrier |
| 07/15/2008 | US7399743 Targeted thrombosis |
| 07/15/2008 | US7399604 Methods and products related to evaluating the quality of a polysaccharide |
| 07/15/2008 | US7399595 Means for the diagnosis and therapy of CTCL |
| 07/15/2008 | US7399492 Composition and method for issue repair and regeneration |
| 07/15/2008 | US7399472 Vaccines |
| 07/15/2008 | US7399468 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
| 07/15/2008 | US7399463 HSA-free formulations of interferon-beta |
| 07/15/2008 | US7399460 Cancer diagnosis; antitumor agents, radiotherapy |
| 07/15/2008 | CA2441836C New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kitfor preparation of the liver cancer-treating composition |
| 07/15/2008 | CA2421120C Quinolinone derivatives as tyrosine kinase inhibitors |
| 07/15/2008 | CA2407606C Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents |
| 07/15/2008 | CA2355175C Soluble compositions of triphenylethylene antiestrogens |
| 07/15/2008 | CA2289086C Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells |
| 07/15/2008 | CA2283327C Cationic lipid compositions targeting angiogenic endothelial cells |
| 07/15/2008 | CA2282184C Stable, pulverulent lycopene formulations, comprising lycopene having a degree of crystallinity of greater than 20% |
| 07/15/2008 | CA2250861C Cyclic adhesion inhibitors |
| 07/15/2008 | CA2231545C Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 07/15/2008 | CA2205557C Monofunctional and/or polyfunctional polylysine conjugates |
| 07/15/2008 | CA2149329C Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/15/2008 | CA2118235C Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 07/10/2008 | WO2008083226A2 Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| 07/10/2008 | WO2008082856A1 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 07/10/2008 | WO2008082840A1 Pim kinase inhibitors as cancer chemotherapeutics |
| 07/10/2008 | WO2008082839A2 Pim kinase inhibitors as cancer chemotherapeutics |
| 07/10/2008 | WO2008082658A2 Cyclitols and their derivatives and their therapeutic applications |
| 07/10/2008 | WO2008082637A1 Composition and methods for modulating a kinase cascade |
| 07/10/2008 | WO2008082579A1 Method for treating cancer |
| 07/10/2008 | WO2008082182A1 A composition containing arazyme for the prevention and treatment of cancer |
| 07/10/2008 | WO2008081942A1 Diagnosis and treatment of cancer by using anti-prg-3 antibody |
| 07/10/2008 | WO2008081927A1 Method for treating cancer using anticancer agent in combination |
| 07/10/2008 | WO2008081914A1 Novel aminopyrimidine derivative as plk1 inhibitor |
| 07/10/2008 | WO2008081910A1 Novel aminopyrimidine derivatives as plk1 inhibitors |
| 07/10/2008 | WO2008081812A1 Anti-tumor peptide and use thereof |
| 07/10/2008 | WO2008081701A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/10/2008 | WO2008081590A1 Medical composition |